Benzinga | Jan 27, 2022 06:46AM EST

Barclays Maintains Overweight on Catalent, Lowers Price Target to $130

Barclays analyst Luke Sergott maintains Catalent (NYSE:CTLT) with a Overweight and lowers the price target from $160 to $130.